Company Active LTD

Company profile

Cellular Systems (Grantham) Limited

Cellular Systems (Grantham) Limited is a UK company with status active founded in 2006 based in North West England.

CRN
05747095
Founded
2006
Age
20

Overview

Legal name
CELLULAR SYSTEMS (GRANTHAM) LIMITED
Region
North West England
Registered address
1ST FLOOR, FAIRCLOUGH HOUSE
CHURCH STREET
CHORLEY
ENGLAND
PR7 4EX
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Dec
2025

Accounts due

Accounts Due

Next accounts due date

23 Mar
2025

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Mar
2024

Accounts filed

Accounts

Last accounts made up date

09 Mar
2024

Confirmation statement filed

Confirmation

Last confirmation statement made up date

17 Mar
2006

Incorporated

Inception

Company registered at Companies House

Public funding

13 awards
First funded
2012
Funded years
2012, 2014, 2015, 2017, 2018, 2020, 2021
Age at first award
6 years

Projects

2021 Collaborative R&D

MediFlex: Human-Centred Design for Sustainable PPE

1 Jan 2021 to 31 Mar 2021

Awarded
£20,459
Total cost £25,574

**This project addresses an identified environmental, healthcare and commercial demand for sustainable alternatives to single-use plastic personal protective equipment (PPE).** As part of the UK's COVID-19 response, the Department of Health and Social Care (DHSC) PPE strategy identifies a need for an additional 5 billion PPE items to address the increased...

2020 Collaborative R&D Lead participant

PommeACE 2 -

1 Dec 2020 to 30 Nov 2021

Awarded
£39,790
Total cost £39,790

**The project addresses an identified healthcare need and commercial demand for high-quality, sustainably-produced bioactive polyphenolic compounds.** Coronaviruses infect cells by binding to the angiotensin-converting-enzyme-2 (ACE2) membrane protein. This can be inhibited by polyphenols, specifically quercetin, increasing resistance to infection. Querce...

2020 Study Lead participant

FungiMAX

1 Nov 2020 to 31 Oct 2021

Awarded
£7,016
Total cost £10,023

**BUSINESS NEED:** Materials derived from chitin (e.g. chitosans, chitooligosaccharides (COSs) and glucosamine) are of growing importance in biomedicine, cosmetics, healthcare, packaging and agriculture. Discussions with IVC Brunel, (the leading white-label supplier of supplements to UK supermarkets) and IVC Nutrition Corporation revealed that the: \* Sup...

2020 Feasibility Studies Lead participant

PommeACE

1 Jun 2020 to 30 Nov 2020

Awarded
£74,877
Total cost £74,877

**The project addresses an identified healthcare need and commercial demand for high-quality, sustainably-produced bioactive polyphenolic compounds.** Development of products derived from fruit and vegetables can support the recovery of individuals by enhancing their immune response, leading to faster recovery time or weakening future reinfection by mutat...

2018 Feasibility Studies

Air Monitor - Protected Crops - Tomatoes

1 Jul 2018 to 31 Dec 2018

Awarded
£9,551
Total cost £13,644

Tomato growers in the UK need to detect Botrytis cinerea/grey mould early in it's development to avoid economic loss. Botrytis impacts both productivity and profitability of the industry year long, with backgrounds of 1- 10% of plants infected throughout the year, reaching 30% at the year end. The aim of this project is to investigate the feasibility of e...

2018 Feasibility Studies Lead participant

Use of nano MIPS to extract valuable compounds from waste streams

1 Mar 2018 to 28 Feb 2019

Awarded
£27,994
Total cost £39,992

Molecularly Imprinted Polymers (MIPs) have been proven for a range of applications including affinity purification. MIP Diagnostics using a revolutionary manufacturing process have developed nano-MIPs. This proprietary method enables much more refined MIPs based products including affinity chromatography media for separation of high value compounds. This ...

2018 BIS-Funded Programmes

Poultry Gut Health

1 Jan 2018 to 31 Mar 2019

Awarded
£11,660
Total cost £21,200

Necrotic Enteritis (NE) is a widespread problem with poultry gut health, leading to losses in the global Poultry industry of over £3bn, a burden of £25-30 million in the UK. We are developing a monitor that will indicate when the poultry are developing this problem in their guts, allowing farmers to take early and effective action, with non-antibiotic int...

2017 Feasibility Studies

Poultry Gut Health

1 Mar 2017 to 30 Nov 2017

Awarded
£11,199
Total cost £15,998

This project is designed to test the feasibility of using e-nose technology as a real time monitoring tool for changes in poultry Gastro-Intestinal Tract (GIT) microflora, specifically Clostridium Perfringens (CP) - the causative bacterium of Necrotic Enteritis (NE). NE can have a dramatic impact on poultry growth and mortality, compromising both animal w...

2015 GRD Proof of Market Lead participant

Market for Campylobacter monitoring / Diagnostic tools - an in depth study

1 Jul 2015 to 31 Dec 2015

Awarded
£24,480
Total cost £40,800

Campylobacter is an issue affecting the UK’s general population and its food and agricultural industries. Over the past 5- 10 years much effort has been made by the government to address the problem, however it still causes 100+ deaths, 22,000 hospitalisations and over 280,000 reported cases a year. In November, 2014 the Food Standards Agency (FSA) reveal...

2015 Collaborative R&D

Early Disease Detection and Monitoring in Farm and Field Acronym: Farm Monitor

1 Apr 2015 to 31 Oct 2017

Awarded
£152,124
Total cost £253,540

Early stage detection of infectious agents in livestock destined for the human food supply chain includes tuberculosis, campylobacter, E coli, avian influenza and micro-organisms that cause mastitis. The agents cause diseases that cost UK and global agriculture billions of pounds every year. This TSB project will manufacture a new diagnostic platform, com...

2014 Feasibility Studies Lead participant

Egg Shell Waste - Investigating the Chemistry of the isolation Processes of High Value Materials

1 Apr 2014 to 31 Mar 2015

Awarded
£46,546
Total cost £70,079

Egg shell waste amounts to 15,000 tonnes per annum in the UK, it is predominantly sent to land fill. This is both bad for the environment and also costs the egg processors hard earned cash. This material, comprising a mineral calcium carbonate and a biological component, proteins and bioactive molecules, has a value. The mineral, at commodity prices, coul...

2012 Vouchers Lead participant

In Vitro study of Campylobacter reduction by Bdellovibrio

1 Nov 2012 to 31 Mar 2013

Awarded
£5,000
Total cost £5,000

Control of food poisoning from Campylobacter, using soil inhabiting bacteria.

Product types

BIS-Funded Programmes Collaborative R&D Feasibility Studies GRD Proof of Market Study Vouchers